Medican Enterprises Financials
| MDCN Stock | USD 0.0001 0.00 0.00% |
Medican |
Medican Enterprises Stock Summary
Medican Enterprises competes with Re Max, and Kennedy Wilson. Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada. Medican Enterprises operates under Real Estate Services classification in the United States and is traded on OTC Exchange. It employs 3 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US58464T2024 |
| Business Address | 3440 East Russell |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medicaninc.com |
| Phone | 800 416 8802 |
| Currency | USD - US Dollar |
Medican Enterprises Key Financial Ratios
Medican Enterprises' financial ratios allow both analysts and investors to convert raw data from Medican Enterprises' financial statements into concise, actionable information that can be used to evaluate the performance of Medican Enterprises over time and compare it to other companies across industries.| Return On Asset | -68.18 | |||
| Beta | 104.43 |
Medican Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medican Enterprises's current stock value. Our valuation model uses many indicators to compare Medican Enterprises value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medican Enterprises competition to find correlations between indicators driving Medican Enterprises's intrinsic value. More Info.Medican Enterprises is considered to be number one stock in return on asset category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medican Enterprises by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medican Enterprises' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medican Enterprises Systematic Risk
Medican Enterprises' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medican Enterprises volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Medican Enterprises correlated with the market. If Beta is less than 0 Medican Enterprises generally moves in the opposite direction as compared to the market. If Medican Enterprises Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medican Enterprises is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medican Enterprises is generally in the same direction as the market. If Beta > 1 Medican Enterprises moves generally in the same direction as, but more than the movement of the benchmark.
Medican Enterprises February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medican Enterprises help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medican Enterprises. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medican Enterprises based on widely used predictive technical indicators. In general, we focus on analyzing Medican Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medican Enterprises's daily price indicators and compare them against related drivers.
| Information Ratio | 0.2087 | |||
| Maximum Drawdown | 1100.0 |
Other Information on Investing in Medican Pink Sheet
Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.